TSE News

Mebiopharm Listed on TOKYO AIM

Update : Jul. 15, 2011

print

[]

TOKYO AIM Inc., ("TOKYO AIM") today welcomed Mebiopharm Co., Ltd. ("Mebiopharm"), a Japanese biotechnology firm, specializing in new drug development for cancer treatment, to the TOKYO AIM market

Further details on TOKYO AIM can be found at:

Contact

Tokyo Stock Exchange Group, Inc.
Corporate Strategy
Tel: +81-3-3666-1361

Top of Page